Filed: 8/14/2024ACC: 0001389932-24-000016
📋 What this filing means
DAFNA CAPITAL MANAGEMENT LLC filed this quarterly 13F‑HR report disclosing 83 equity positions with a total reported market value of $418.57M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
83
Positions
$418.57M
Total AUM (reported)
46.29M
Total Shares
Allocation by class
COM$261.46M62.5%
COM NEW$58.26M13.9%
ETF$55.33M13.2%
SPONSORED ADR$11.04M2.6%
SPONSORED ADS$7.06M1.7%
SHS$5.99M1.4%
COMMON STOCK$4.75M1.1%
Portfolio Concentration
Top 3$90.38M21.6%
4–10$109.66M26.2%
11–25$124.67M29.8%
Rest$93.85M22.4%
Top 3 weight
21.6%
Top 10 weight
47.8%
Voting Authority Distribution
Total shares with voting rights: 46.29M
Sole
Full voting authority
46.29M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole83
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings83
Rows:
SPDR S&P BIOTECH ETF
SOLEShares445K
TypeSH
Market value$41.26M
9.86%
Sole
445K
Shared
0.00
None
0.00
STEREOTAXIS INC
SOLEShares13.68M
TypeSH
Market value$24.90M
5.95%
Sole
13.68M
Shared
0.00
None
0.00
MERUS N V
SOLEShares409.44K
TypeSH
Market value$24.23M
5.79%
Sole
409.44K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares398.10K
TypeSH
Market value$21.57M
5.15%
Sole
398.10K
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
SOLEShares511.89K
TypeSH
Market value$19.87M
4.75%
Sole
511.89K
Shared
0.00
None
0.00
IDEAYA BIOSCIENCES INC
SOLEShares422.21K
TypeSH
Market value$14.82M
3.54%
Sole
422.21K
Shared
0.00
None
0.00
ATRICURE INC
SOLEShares639.17K
TypeSH
Market value$14.55M
3.48%
Sole
639.17K
Shared
0.00
None
0.00
ISHARES NASDAQ BIOTECH INDX
SOLEShares102.50K
TypeSH
Market value$14.07M
3.36%
Sole
102.50K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares657.07K
TypeSH
Market value$13.49M
3.22%
Sole
657.07K
Shared
0.00
None
0.00
BLUEPRINT MEDICINES CORP
SOLEShares104.76K
TypeSH
Market value$11.29M
2.70%
Sole
104.76K
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares80.97K
TypeSH
Market value$11.04M
2.64%
Sole
80.97K
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares273.74K
TypeSH
Market value$10.67M
2.55%
Sole
273.74K
Shared
0.00
None
0.00
VIKING THERAPEUTICS INC
SOLEShares189.12K
TypeSH
Market value$10.03M
2.40%
Sole
189.12K
Shared
0.00
None
0.00
NEUROCRINE BIOSCIENCES INC
SOLEShares71.61K
TypeSH
Market value$9.86M
2.36%
Sole
71.61K
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares806.97K
TypeSH
Market value$9.51M
2.27%
Sole
806.97K
Shared
0.00
None
0.00
DAY ONE BIOPHARMACEUTICALS I
SOLEShares666.46K
TypeSH
Market value$9.18M
2.19%
Sole
666.46K
Shared
0.00
None
0.00
KURA ONCOLOGY INC
SOLEShares423.50K
TypeSH
Market value$8.72M
2.08%
Sole
423.50K
Shared
0.00
None
0.00
TANDEM DIABETES CARE INC
SOLEShares204.21K
TypeSH
Market value$8.23M
1.97%
Sole
204.21K
Shared
0.00
None
0.00
MORPHIC HOLDING INC
SOLEShares231.75K
TypeSH
Market value$7.90M
1.89%
Sole
231.75K
Shared
0.00
None
0.00
UROGEN PHARMA LTD
SOLEShares469K
TypeSH
Market value$7.87M
1.88%
Sole
469K
Shared
0.00
None
0.00
BIOHAVEN LTD
SOLEShares218.73K
TypeSH
Market value$7.59M
1.81%
Sole
218.73K
Shared
0.00
None
0.00
DEXCOM INC
SOLEShares65.55K
TypeSH
Market value$7.43M
1.78%
Sole
65.55K
Shared
0.00
None
0.00
AXOGEN INC
SOLEShares935.89K
TypeSH
Market value$6.78M
1.62%
Sole
935.89K
Shared
0.00
None
0.00
EDGEWISE THERAPEUTICS INC
SOLEShares290.20K
TypeSH
Market value$5.23M
1.25%
Sole
290.20K
Shared
0.00
None
0.00
LARIMAR THERAPEUTICS INC
SOLEShares639.97K
TypeSH
Market value$4.64M
1.11%
Sole
639.97K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SPDR S&P BIOTECH ETFSOLE | ETF | 445K | SH | $41.26M 9.86% | 445K | 0.00 | 0.00 |
STEREOTAXIS INCSOLE | COM NEW | 13.68M | SH | $24.90M 5.95% | 13.68M | 0.00 | 0.00 |
MERUS N VSOLE | COM | 409.44K | SH | $24.23M 5.79% | 409.44K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 398.10K | SH | $21.57M 5.15% | 398.10K | 0.00 | 0.00 |
REVOLUTION MEDICINES INCSOLE | COM | 511.89K | SH | $19.87M 4.75% | 511.89K | 0.00 | 0.00 |
IDEAYA BIOSCIENCES INCSOLE | COM | 422.21K | SH | $14.82M 3.54% | 422.21K | 0.00 | 0.00 |
ATRICURE INCSOLE | COM | 639.17K | SH | $14.55M 3.48% | 639.17K | 0.00 | 0.00 |
ISHARES NASDAQ BIOTECH INDXSOLE | ETF | 102.50K | SH | $14.07M 3.36% | 102.50K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 657.07K | SH | $13.49M 3.22% | 657.07K | 0.00 | 0.00 |
BLUEPRINT MEDICINES CORPSOLE | COM | 104.76K | SH | $11.29M 2.70% | 104.76K | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 80.97K | SH | $11.04M 2.64% | 80.97K | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 273.74K | SH | $10.67M 2.55% | 273.74K | 0.00 | 0.00 |
VIKING THERAPEUTICS INCSOLE | COM | 189.12K | SH | $10.03M 2.40% | 189.12K | 0.00 | 0.00 |
NEUROCRINE BIOSCIENCES INCSOLE | COM | 71.61K | SH | $9.86M 2.36% | 71.61K | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 806.97K | SH | $9.51M 2.27% | 806.97K | 0.00 | 0.00 |
DAY ONE BIOPHARMACEUTICALS ISOLE | COM | 666.46K | SH | $9.18M 2.19% | 666.46K | 0.00 | 0.00 |
KURA ONCOLOGY INCSOLE | COM | 423.50K | SH | $8.72M 2.08% | 423.50K | 0.00 | 0.00 |
TANDEM DIABETES CARE INCSOLE | COM NEW | 204.21K | SH | $8.23M 1.97% | 204.21K | 0.00 | 0.00 |
MORPHIC HOLDING INCSOLE | COM | 231.75K | SH | $7.90M 1.89% | 231.75K | 0.00 | 0.00 |
UROGEN PHARMA LTDSOLE | COM | 469K | SH | $7.87M 1.88% | 469K | 0.00 | 0.00 |
BIOHAVEN LTDSOLE | COM | 218.73K | SH | $7.59M 1.81% | 218.73K | 0.00 | 0.00 |
DEXCOM INCSOLE | COM | 65.55K | SH | $7.43M 1.78% | 65.55K | 0.00 | 0.00 |
AXOGEN INCSOLE | COM | 935.89K | SH | $6.78M 1.62% | 935.89K | 0.00 | 0.00 |
EDGEWISE THERAPEUTICS INCSOLE | COM | 290.20K | SH | $5.23M 1.25% | 290.20K | 0.00 | 0.00 |
LARIMAR THERAPEUTICS INCSOLE | COM | 639.97K | SH | $4.64M 1.11% | 639.97K | 0.00 | 0.00 |
Page 1 of 4